The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
ConditionInfluenza
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-99
SponsorUniversity of Colorado, Denver
About this trial
This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.
Eligibility criteria
Qualifiers
At least 6 months of age
Admitted to an inpatient unit at a participating health system
Disqualifiers
At least 6 months of age
Admitted to an inpatient unit at a participating health system
Trial design
Treatments tested in this trial
- Existing Influenza Vaccination Practices
- Standardized inpatient influenza vaccination program
Treatment groups
22,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Colorado, Denver
Lead sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
Seattle Children's Hospital
Collaborator
Source ClinicalTrials.gov